SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-007979
Filing Date
2024-05-13
Accepted
2024-05-13 16:42:27
Documents
4
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240625xdef14a.htm DEF 14A 1014562
2 GRAPHIC tmb-20240625xdef14a_a003.jpg GRAPHIC 74733
3 GRAPHIC tmb-20240625xdef14a_bg001.jpg GRAPHIC 122670
4 GRAPHIC tmb-20240625xdef14a_bg002.jpg GRAPHIC 123375
  Complete submission text file 0001558370-24-007979.txt   1458060
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32295 | Film No.: 24939796
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)